Références

1. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018 ; 4 : 1.

2. Zuberbier T, Abdul Latiff A, Aggelidis X, et al. A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative. Clin Transl Allergy 2023 ; 13 : e12299.

3. Braun C, Nosbaum A. Histoire naturelle de la dermatite atopique: Natural History of Atopic Dermatitis. Ann Dermatol Venereol 2019 ; 146 (12S3) : 12S58-12S66.

4. Annesi-Maesano I, Biagioni B, D’AmatoG, CecchiL. L’exposome : un concept innovant englobant les facteurs environnementaux du développement des maladies allergiques. Revue Française d’Allergologie 2020 ; 60 : 454-60.

5. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. New Engl J Med 2002 ; 347 : 911-20.

6. Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: part I-systemic therapy. J Eur Acad Dermatol Venereol 2022 ; 36 : 1409-31.

7. Cart-Tanneur M, Erpeldinger S, Pipard T,Nicolas JF, Nosbaum A. Dermatite atopique. Traitements locaux: efficaces dans 90 % des cas. Rev Prat Med Gen 2019 ; 33 : 279-84.

8. Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: part II - non-systemic treatments and treatment recommendations for special AEpatient populations. J Eur Acad Dermatol Venereol 2022 ; 36 : 1904-26.

9. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018 ; 32 : 657-82.

10. Silverberg JI, Simpson EL. Associations of childhood eczema severity : a US population-based study. Dermatitis 2014 ; 25 : 107-14.

11. Inserm. Microbiote intestinal (flore intestinale). Une piste sérieuse pour comprendre l’origine de nombreuses maladies, 2021 : https://www.inserm.fr/dossier/microbiote-intestinal-flore-intestinale/

12. Braun C, Patra V, Lina G, Nicolas JF, Vocanson M, Nosbaum A. The role of skin dysbiosis in atopic dermatitis. Eur J Dermatol 2022 ; 32 : 439-44.

13. Mahmud MR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health : gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes 2022 ; 14 : 2096995.

14. O’Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. Bioessays 2016 ; 38 : 1167-76.

15. Hennino A, Bérard F, Nicolas JF. La dermatite atopique n’est pas une maladie allergique. Presse Med 2005 ; 34 : 78-80.

16. Braun C, Nosbaum A. Food avoidance is not a reliable option as a first-line treatment for atopic dermatitis. Arch Pediatr 2021 ; 28 : 619-20.

17. Saint-Mezard P, Chavagnac C, Bosset S, et al. Psychological stress exerts an adjuvant effect on skin dendritic cell functionsin vivo. J Immunol 2003 ; 171 : 4073-80.

18. Achten R, Van der Rijst L, Piena M, et al. Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis. Acta Derm Venereol 2023 ; 103 : adv00881.

19. Yasuda KI, Ishiuji Y, Ebata T, et al. Monitoring Sleep and Scratch Improves Quality of Life in Patients with Atopic Dermatitis. Acta Derm Venereol 2023 ; 103 : adv11922.

20. Lejay S, Darrigade AS, Dupre D, et al. Use of therapeutic patient education tools for atopic dermatitis: A French nationalsurvey. J Eur Acad Dermatol Venereol 2023 ; 37 : e1271-e1273.

21. Vestergaard C, Skovsgaard C, Johansen C, Deleuran M, Thyssen JP. Treat- to-Targetin Atopic Dermatitis. Am J Clin Dermatol 2024 ; 25 : 91-8.



22. Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov 2023 ; 22 : 662-80.